AngioDynamics
ANGO
177 hedge funds and large institutions have $813M invested in AngioDynamics in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 71 reducing their positions, and 18 closing their positions.
33% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 18
1.84% more ownership
Funds ownership: 99.01% → 100.84% (+1.8%)
2% more funds holding
Funds holding: 174 → 177 (+3)
0% more capital invested
Capital invested by funds: $810M → $813M (+$2.38M)
27% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 71
74% less call options, than puts
Call options by funds: $304K | Put options by funds: $1.15M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$22.6M |
| 2 |
Lazard Asset Management
New York
|
+$20.3M |
| 3 |
BC
Broadfin Capital
New York
|
+$6.42M |
| 4 |
BlackRock
New York
|
+$6.23M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$7.96M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.87M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$4.57M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$4.35M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$4.25M |
ANGO Hedge Fund Activity: Q3 2018 in Review
177 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2018, worth a combined $813M — up 0.29% from $810M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ANGO positions and 18 closed out — a net gain of 6 holders — while 52 added to existing stakes and 71 trimmed.
The largest buyer was Victory Capital Management, opening a new position worth an estimated $22.6M. The largest seller was Kennedy Capital Management, cutting an estimated $7.96M.
- 177 institutional investors held AngioDynamics (ANGO) as of Q3 2018, up from 174 in Q2 2018.
- Funds reported $813M of AngioDynamics stock for Q3 2018, up 0.29% quarter-over-quarter.
- 24 funds opened new AngioDynamics positions in Q3 2018 and 18 closed out, a net change of +6 holders.
- The largest AngioDynamics buyer in Q3 2018 was Victory Capital Management, an estimated $22.6M added.
- The largest AngioDynamics seller in Q3 2018 was Kennedy Capital Management, an estimated $7.96M sold.
Based on aggregated 13F filings for Q3 2018.